Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$4.80
-1.4%
C$4.81
C$3.00
C$5.23
C$106.79M1.0713,424 shs17,701 shs
BioSyent Inc. stock logo
RX
BioSyent
C$11.98
+0.7%
C$11.58
C$9.20
C$12.13
C$137.02M0.934,221 shs183 shs
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
C$0.00
C$0.17
C$0.65
C$89.95MN/A2.66 million shs19.70 million shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.26
C$0.21
C$0.04
C$0.36
C$39.40M0.32199,458 shs328,039 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-0.20%+1.25%-2.21%+21.14%+39.94%
BioSyent Inc. stock logo
RX
BioSyent
+0.85%+1.71%-0.42%+19.00%+18.41%
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
0.00%0.00%0.00%0.00%0.00%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-10.34%-16.13%+33.33%+33.33%+420.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
BioSyent Inc. stock logo
RX
BioSyent
N/AN/AN/AN/AN/AN/AN/AN/A
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
N/AN/AN/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
2.00
HoldC$4.50-7.60% Downside
BioSyent Inc. stock logo
RX
BioSyent
0.00
N/AN/AN/A
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
0.00
N/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$40.13M2.70C$0.32 per share15.22C$2.51 per share1.94
BioSyent Inc. stock logo
RX
BioSyent
C$34.06M4.00C$3.87 per share3.07C$3.22 per share3.69
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
C$31.37M0.00N/A10.63C$0.26 per share0.00
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.01 per share35.00C$0.01 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$15.53M-C$1.00N/AN/A-38.70%-25.27%-2.89%N/A
BioSyent Inc. stock logo
RX
BioSyent
C$7.02MC$0.6219.31N/A20.60%20.01%12.86%N/A
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
N/A-C$0.26N/AN/AN/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.66M-C$0.01N/AN/AN/A-117.77%-30.77%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$0.204.11%N/AN/A N/A
BioSyent Inc. stock logo
RX
BioSyent
C$0.181.51%N/A29.21%N/A
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
N/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
86.50
1.56
1.01
BioSyent Inc. stock logo
RX
BioSyent
2.90
3.92
6.91
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
16.77
1.28
0.50
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
4.23
0.10
0.84

Institutional Ownership

CompanyInstitutional Ownership
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
65.20%
BioSyent Inc. stock logo
RX
BioSyent
1.37%
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.37%
BioSyent Inc. stock logo
RX
BioSyent
33.65%
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
N/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9122.25 millionN/ANot Optionable
BioSyent Inc. stock logo
RX
BioSyent
N/A11.44 millionN/ANot Optionable
The Green Organic Dutchman Holdings Ltd. stock logo
TGOD
Green Organic Dutchman
41529.14 millionN/ANot Optionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A151.52 millionN/ANot Optionable

Recent News About These Companies

Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Here's Why
Voyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Should You Sell?
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Time to Sell?
Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - Here's Why

Media Sentiment Over Time

Top Headlines

View All Headlines
HLS Therapeutics stock logo

HLS Therapeutics TSE:HLS

C$4.80 -0.07 (-1.44%)
As of 01:10 PM Eastern

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

BioSyent stock logo

BioSyent CVE:RX

C$11.98 +0.08 (+0.67%)
As of 10:23 AM Eastern

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.

Green Organic Dutchman stock logo

Green Organic Dutchman TSE:TGOD

The Green Organic Dutchman Holdings Ltd., through its subsidiaries, produces and sells organic cannabis in Canada. It offers organic cannabis products, such as cannabis plants, cannabis plant seeds, dried cannabis, fresh cannabis, cannabis oils, cannabis topicals, cannabis extracts, and edible cannabis to retailers or distributors, and federal licensed entities. The Green Organic Dutchman Holdings Ltd. was incorporated in 2016 and is headquartered in Mississauga, Canada.

Voyageur Pharmaceuticals stock logo

Voyageur Pharmaceuticals CVE:VM

C$0.26 0.00 (0.00%)
As of 12:57 PM Eastern

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.